BETA

Activities of Emmanuel MAUREL related to 2021/2013(INI)

Shadow opinions (1)

OPINION on a pharmaceutical strategy for Europe
2021/07/14
Committee: JURI
Dossiers: 2021/2013(INI)
Documents: PDF(148 KB) DOC(52 KB)
Authors: [{'name': 'Luisa REGIMENTI', 'mepid': 197790}]

Amendments (3)

Amendment 9 #
Draft opinion
Paragraph 1 a (new)
1a. Stresses that the lack of strategic autonomy and the high level of EU dependence in a sector as essential as healthcare and pharmaceuticals is the concrete expression of free trade taken to extremes in line the policies encouraged for decades by the European Commission;
2021/06/03
Committee: JURI
Amendment 13 #
Draft opinion
Paragraph 1 b (new)
1b. Stresses that European industry has been severely affected by the COVID- 19 pandemic; underlines its strong dependence regarding supplies; calls for long-term measures to consolidate European industrial sovereignty, making it stronger, more integrated, more locally based and more robust, so as to avoid any disruptions in supply chains;
2021/06/03
Committee: JURI
Amendment 75 #
Draft opinion
Paragraph 5 a (new)
5a. Calls for an EU health exemption to be notified to the WTO and incorporated into all past and future trade agreements, incorporating zero tariffs for pharmaceutical products, while allowing the parties to accord public funding to their national pharmaceuticals and health sectors; calls for a provision ruling out any future dispute arising from our FTA partners regarding health issues;
2021/06/03
Committee: JURI